Meta-level question: how do you evaluate evidence for aniracetam when the human data is thin and most trials are small?
Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
If you need three other compounds to notice the first one, you have not tested the first one.
Posting to be argued with, mainly.
Test one thing at a time. It feels slower and it is the only way to learn anything. Eight months in on aniracetam and it lines up.
My rule, after years of this: if it cannot survive being written down with the numbers attached, it is marketing. Eight months in on aniracetam and it lines up.